Akiram has developed a new type of targeted radioimmunotherapy with the potential to become first-in-class. In animal studies, the survival rate has been 100%, and the tumours have been eradicated with just one treatment.
Encare has developed a cloud-based software solution that helps hospitals follow best practices during surgery, reducing complications, increasing patient satisfaction, and lowering costs for healthcare providers.
PharmNovo develops a novel drug for nerve pain, where there is a high, unmet need for effective and safe treatments. The candidate PN6047 shows effective pain relief in animal models, without the negative side effects associated with existing drugs.
Capitainer offers a more convenient and cost-efficient way to take blood samples. The company’s products are designed for home sampling and deliver an exact amount of blood, which is essential to get accurate results.
Lipigon develops orphan drugs for illnesses due to disorders in how the body handles fat. The company’s major program, Lipsense, focuses on the illness, HoFH, where there is, today, no sufficient treatment.